Table 5:

Secondary outcome evaluation

Secondary OutcomeEnterprise n = 62Tubridge n = 82Odds Ratio (95% CI)P Value
Immediate technique success rate59/62 (95.16%)79/82 (96.34%)1.34 (0.26–6.87).726
Death or target vessel–related stroke
    30 days7/62 (11.29%)11/82 (13.41%)0.821 (0.299–2.258).703
    90 days8/62 (12.90%)12/82 (14.63%)0.864 (0.330–2.263).766
    1 yr9/62 (14.52%)14/82 (17.07%)0.825 (0.332–2.051).678
Mortality rate
    30 days1/62 (1.61%)3/82 (3.66%)0.432 (0.044–4.253).634
    90 days1/62 (1.61%)4/82 (4.88%)0.320 (0.035–2.934).391
    1 yra2/62 (3.23%)4/82 (4.88%)0.650 (0.115–3.668).699
Hemorrhagic stroke related to target vessel
    30 days2/62 (3.23%)5/82 (6.1%)0.531 (0.096–2.738).699
    90 days2/62 (3.23%)5/82 (6.1%)0.531 (0.096–2.738).699
    1 yr2/62 (3.23%)5/82 (6.1%)0.531 (0.096–2.738).699
Ischemic stroke related to target vessel
    30 days4/62 (6.54%)6/82 (7.32%)0.874 (0.236–3.239).874
    90 days5/62 (8.06%)6/82 (7.32%)1.111 (0.323–3.822).867
    1 yr6/62 (9.68%)8/82 (9.76%)0.991 (0.325–3.109).987
Aneurysm rupture
    30 days1/62 (1.61%)3/82 (3.66%)0.357 (0.072–1.783).634
    90 days1/62 (1.61%)3/82 (3.66%)0.357 (0.072–1.783).634
    1 yr1/62 (1.61%)3/82 (3.66%)0.357 (0.072–1.783).634
General adverse events
    30 days26/62 (41.94%)42/82 (51.22%)0.808 (0.293–2.229).269
    90 days26/62 (41.94%)42/82 (51.22%)0.808 (0.293–2.229).269
    1 year33/62 (53.23%)46/82 (56.10%)0.938 (0.644–1.365).88
Rate of intrastent stenosis2/53 (3.77%)4/73 (5.48%)0.676 (0.119–3.837)1
Rate of intrastent thrombosis1/59 (1.69%)6/79 (7.59%)0.215 (0.025–1.839).273

  • ↵a Two subjects died during follow-up for reasons unrelated to the target vessels (1 each in Tubridge and control groups).